Abstract Previous studies have shown that extracranial-intracranial (EC-IC) bypass surgery has no preventive effect on subsequent ipsilateral ischemic stroke in patients with symptomatic atherosclerotic internal carotid occlusion and hemodynamic cerebral ischemia. A few studies have assessed whether an urgent EC-IC bypass surgery is an effective treatment for main trunk stenosis or occlusion in acute stage. The authors retrospectively reviewed 58 consecutive patients who underwent urgent EC-IC bypass for symptomatic internal carotid artery or the middle cerebral artery stenosis or occlusion between January 2003 and December 2011. Clinical characteristics and neuroimagings were evaluated and analyzed. Based on preoperative angiogram, responsible lesions were the internal carotid artery in 19 (32.8 %) patients and the middle cerebral artery in 39 (67.2 %). No hemorrhagic complication occurred. Sixty-nine percent of patients showed improvement of neurological function after surgery, and 74.1 % of patients had favorable outcome. Unfavorable outcome was associated with insufficient collateral flow and new infarction after bypass surgery.
Introduction
Recent randomized clinical trial in patients with atherosclerotic internal carotid artery (ICA) occlusion to medical or extracranial-intracranial (EC-IC) bypass surgery in chronic stage found that superficial temporal artery (STA)-middle cerebral artery (MCA) bypass provided no benefit over medical therapy [8] . By contrast, surgical revascularization may be effective to some patients who suffered from medicationresistance hemodynamic stroke in acute stage [3] [4] [5] [6] [7] 10 ]. However, safety and efficacy of surgical revascularization for ischemic stroke in acute stage is still controversial. We have reported the efficacy of urgent embolectomy for the ICA or MCA occlusion caused by embolism [4, 6] . In the present study, we analyzed our experience with early EC-IC bypass in acute ischemic stroke and stroke in progress due to arteriosclerosis.
Patients and methods

Patient population
From January 2003 to December 2011, 101 patients with stenoocclusive disease at the anterior circulation underwent EC-IC bypass. Of the 101 patients who underwent 104 procedures, there were 59 patients treated with urgent EC-IC bypass to treat acute ischemic stroke. Crescendo transient ischemic attack resistance to medical treatment and progressive ischemic stroke due to the steno-occlusive disease of ICA or MCA were also treated with direct bypass. The EC-IC bypass for moyamoya or atherosclerotic patients in the chronic phase was excluded. We retrospectively analyzed hospital records, neuroimaging studies, and operative reports. The study protocol was approved by the institutional ethics committee.
Management of patients
On admission, the patient presenting with speech disturbance, motor weakness, and/or cognitive dysfunction initially underwent computed tomography (CT). Based on neurological findings and CT, main trunk stenosis or occlusion was suspected. Main artery stenosis or occlusion at the ICA or MCA was generally detected using magnetic resonance imaging (MRI) and confirmed with cerebral angiography. Embolus or atherosclerosis was diagnosed based on the past history such as atrial fibrillation and neuroimages. The embolic stroke in patients with insufficient endovascular recanalization was treated by the open embolectomy [3, 4, 6, 8] . The EC-IC bypass was performed for steno-occlusive atherosclerosis. When it was difficult to distinguish the atherosclerosis from the embolus preoperatively, the affected artery was directly visualized and the appropriate surgery was carried out. Surgical indications of urgent revascularization were previously reported in detail [4, 6] . Briefly, inclusion criteria were the following: (1) the patient who needed no support for daily life before ictus; (2) severe neurological deficits with/without cognitive dysfunction were present; (3) diffusion-weighted images revealed no abnormal findings or minimum early signs of ischemia on admission; (4) main artery stenosis or occlusion causing symptoms was confirmed; (5) medical treatment (bolus intravenous injection of heparin (5,000 IU) followed by weight-based dose of heparin infusion and oral antiplatelet drugs such as aspirin and clopidogrel) failed sufficient recanalization and progression of ischemic symptoms; and (6) follow-up neuroimagings showed no new infarction at the affected vascular territory.
Clinical characteristics and outcomes
The location of stenosis or occlusion was divided into five groups: cervical ICA, intradural ICA, proximal M1 segment of MCA, distal M1 segment, and M2 segment. Preoperative neurological conditions of patients were assessed by Glasgow Coma Scale. Patients' outcome at discharge was evaluated with Glasgow Outcome Scale and divided in two categories: favorable outcome (good recovery and moderate disability) or unfavorable outcome (severe disability, vegetative state, and dead). Collateral flow through anterior communicating artery, posterior communicating artery, and/or leptomeningeal anastomosis were checked by angiography and categorized into three groups: (1) good flow, there was no flow delay comparing with non-affected side in the arterial phase; (2) moderate flow, some arterial flow delay in the arterial phase without avascular area in the capillary phase; and (3) poor flow, presence of avascular area in the capillary phase. Postoperatively, infarction area was evaluated and followed using CT and/or MRI.
Surgical techniques
EC-IC bypass was undertaken to restore cerebral blood flow at the affected territory. The great majority of patients underwent urgent single or double STA-MCA anastomosis. Generally, M4 segment was selected for the recipient. Based on intraoperative qualitative indocyanine green (ICG) videoangiography and/or Doppler flowmeter findings, single or double anastomosis was carried out. Control ICG videoangiography before anastomosis confirmed recipient cortical arteries, which had slow antegrade or retrograde filling due to the atherosclerosis. The single bypass was performed between the STA and one of the recipients. After the first bypass was complete, follow-up ICG determined if the blood flow had improved. If the blood flow increase was observed at both frontal and temporal cortical arteries, we judged that the single bypass was sufficient. By contrast, when the blood flow increased at only frontal (or temporal) lobe, the second bypass was carried out between the STA and the one of cortical arteries at the temporal (or frontal) lobe.
Statistical analysis
Univariate analyses employed the Pearson's χ 2 test (or Fisher's exact test when the expected frequency of events was <5) and unpaired t test to evaluate statistical significance between favorable and unfavorable outcomes of patients. Data analysis was carried out using a statistical software package (PASW Statistics 18, SPSS Japan). Significance was assigned at P<0.05.
Results
Direct bypass was not performed in one patient because the patient did not have sufficient recipient vessels on the exposed brain surface. Therefore, 58 patients were enrolled on this urgent EC-IC bypass study. Although intravenous tissue plasminogen activator (tPA) was used in patients with embolic stroke, ischemic stroke due to atherosclerosis was not treated using tPA. Therefore, all patients in the present study did not undergo intravenous tPA therapy. Among 58 patients, 34 patients (58.6 %) underwent bypass surgery as soon as possible on day 0. The majority of other 24 patients underwent the surgical treatment up to day 2. Fifteen (25.9 %) and nine patients (15.5 %) presented with progressive ischemic stroke and crescendo transient ischemic attack, respectively. There were 40 male and 18 female patients, whose ages ranged from 35 to 87 years old (70.5±10.5 years; mean±SD). Table 1 shows demographic data of the patients. Forty three (74.1 %) of 58 patients presented with hemiparesis, 38 (65.5 %) with consciousness disturbance, and 20 (34.5 %) with aphasia. In three cases, open embolectomy was initiated for thrombo-embolic lesions. However, recanalization was not present, and bypass procedure was carried out. Single bypass was achieved in 37 patients and double bypasses in 21. The posterior auricular artery [2] was used as the donor artery in only one patient because the sufficient STA was not present. The responsible arteries were ICA in 19 patients and MCA in 39. Neurological functions improved in 40 (69.0 %) patients after surgery. The bypass surgery did not prevent the new infarction at the affected vascular territory in 23 patients (39.7 %). Complications during perioperative periods are presented in Table 2 . Major complications happened in four patients. They included the perforator infarction (case 2) probably due to hemodynamic change [1] and remote infarction (posterior cerebral artery territory). Two patients developed myocardial infarction and one died due to the myocardial infarction. No hemorrhagic infarction happened after bypass. Postoperative MR angiography and/or angiogram were performed on 38 of the 58 patients, 37 of whom had patent bypasses.
Forty-three (74.1 %) and 15 (25.9 %) patients had favorable (good recovery, 29; moderate disability, 14) and unfavorable (severe disability, 14; vegetative state, 0; dead, 1) outcomes, respectively. Favorable and unfavorable outcomes after urgent STA-MCA bypass were detailed in Table 3 . Univariate analysis identified two significant associations for unfavorable outcome: insufficient collateral flow (P=.003) and new infarction after surgery (P<.001). However, age, sex, side, affected artery, and single bypass were not risk factors of unfavorable outcome. This 70-year-old man presented with right hemiparesis, aphasia, agnosia, and acalculia. MRI demonstrated small ischemic lesions on diffusion-weighted images (Fig. 1) , and subsequent angiograms disclosed the left M1proximal occlusion with moderate leptomeningeal collateral flow (Fig. 1) . Medical treatment was not effective, and surgical treatment was performed on day 0. He underwent STA-MCA bypass. After fronto-temporal craniotomy, retrograde blood flow of cortical arteries was confirmed. Firstly, the parietal branch was anastomosed to the precentral artery with 18 min occlusion time. After anastomosis, blood flow increased in ascending frontal and temporal cortical arteries, but not parietal arteries. Therefore, second bypass was carried out between the frontal branch and the anterior parietal artery. The second occlusion time of M4 arteries was 22 min. Postoperatively, he recovered well, and neurological symptoms were resolved on day 1. No new infarction was seen on CT and MRI. He was discharged without neurological deficits on day 9. Postoperative angiogram 3 months later revealed the STA fed the left MCA territory (Fig. 2) .
Illustrative case 2
A 70-year-old woman was transferred with global aphasia and without motor weakness. Neuroimages disclosed an M2 severe stenosis (Fig. 3) . The lateral lenticulostriate arteries originated from the stenotic portion (Fig. 3) . She underwent single STA-MCA anastomosis uneventfully. After surgery, aphasia improved; however, right hemiparesis developed. Follow-up CT scans revealed new infarction in the basal ganglia and coronal radiation fed by the lateral lenticulostriate arteries (Fig. 4) . Postoperative angiogram was not performed. She was transferred to a rehabilitation hospital.
Discussion
Since there are only a few reports concerning urgent EC-IC bypass in atherosclerotic steno-occlusive disease, we retrospectively evaluated 58 consecutive patients who underwent urgent EC-IC bypass surgery in an attempt to augment blood flow of ischemic brain. In general, early antegrade recanalization is the optimal treatment for ischemic stroke. Although intravenous, intraarterial, and mechanical thrombolysis are accepted as a standard treatment in acute phase, they are often unsatisfactory. Additionally, late antegrade recanalization has a risk of reperfusion-related hemorrhagic complication. We previously reported the efficacy of open embolectomy in patients with cardioembolic MCA or ICA occlusion [4, 6] . In patients with symptomatic ICA or MCA arteriosclerosis except for segmental cervical ICA stenosis, antegrade surgical revascularization is usually difficult. Therefore, EC-IC bypass is applied and augments cerebral blood flow (CBF) with low-flow reperfusion. Emergency EC-IC bypass would improve neurological deficits resulting from a small amount of blood flow into ischemic brain related to steno-occlusion of arteriosclerosis. Nussbaum et al. [7] demonstrated excellent results of emergency bypass in 13 carefully selected patients. Majority of patients (84.6 %) suffered ICA or MCA dissection, not atherosclerosis. All patients improved from their preoperative neurological status, and eight (61.5 %) patients recovered completely within 6 months after surgery. New infarction at the affected side was observed in only one patient. Hwang and colleagues [5] presented their urgent EC-IC bypass results in nine patients with relatively small infarction (<30 mL), increased perfusion/diffusion mismatch (>120 %), and fluctuating or progressive symptoms resistance to medical or endovascular therapy. They concluded that urgent bypass was useful in highly selected patients evaluated with multimodal and advanced CT and MRI. The CBF study is one of useful tools to assess necessity of revascularization surgery. Recent advances of MRI perfusion images without contrast medium demonstrated the potential of becoming the standard tool to estimate regional CBF in acute ischemic stroke [9] . However, it is very difficult to judge a treatable penumbra area.
In the present study, we found that 69.0 % of patients showed an improvement of neurological function after surgery although new infarction area on CT or MRI developed in 40 % patients after bypass surgery. The risk factor of unfavorable outcome was new infarction and collateral flow. However, age, side, sex, and affected location were not associated with unfavorable outcome. The importance of collateral flow has been reported in patients undergoing urgent cerebral revascularization surgery [3, 4, 11] . In this study, collateral flow was evaluated with cerebral angiography and therapeutic penumbra was assumed according to follow-up CT scan.
There were no hemorrhagic infarctions as a complication in this study. This result was consistent with recent investigations [5, 7] . However, previous study [11] demonstrated that 4 (11 %) of 35 patients had hemorrhagic infarction after urgent bypass surgery. This study probably included patients suffering from cardio-embolic stroke. In general, atherosclerosis gradually affects main trunk arteries compared with embolic stroke. We reported the hemorrhagic infarction after open embolectomy happened in 3 (10 %) of 30 patients [3] . Therefore, low flow bypass surgery comparing with embolectomy and carotid endarterectomy may be a relative low risk of hemorrhagic transformation. According to recent publications [5, 7] of urgent EC-IC bypass, no reperfusionrelated complications were observed. In the present study, perforator infarction occurred after bypass surgery in the presented case 2. Severe stenosis may result in occlusion due to the counter blood supply through the anastomosis. Our findings indicated that apart from improvement of cortical blood flow, perforating artery occlusion can also occur after bypass surgery. Therefore, special attention should be paid in patients with perforating arteries originating from the severely stenotic artery.
Conclusions
We reviewed 58 patients who underwent urgent EC-IC bypass and presented the surgical results. This study is the largest series to date. However, the present study has a number of shortcomings that should be addressed. It does not include sufficient CBF evaluation, long-term follow-up, and a randomized medical control group. Until further studies without these shortcomings are performed, the efficacy and safety of urgent EC-IC bypass for symptomatic ICA or MCA arteriosclerosis cannot be determined. 
Comments
Akitsugu Kawashima, Tokyo, Japan This article describes excellent results with emergency EC-IC bypass in a big cohort of acute ischemic stroke cases, induced by atherosclerotic stenosis or occlusion of the ICA or MCA. The authors concluded that 69 % of the patients improved and only 8.6 % worsened by this procedure. Emergency EC-IC bypass for acute ischemia has been traditionally considered a contraindication, due to the potential reperfusion ischemic injury 1 . However, the authors reported few surgical complications, especially no hemorrhagic complications, despite the large number of cases. Recently, some papers stated similar findings 2, 3 . These data may become also valuable for management by surgical acute flow replacement in general. Particular attention deserves the described 74.1 % favorable outcome (good recovery, 50 % and moderate disability, 24.1 % as Glasgow Outcome Scale) in patients treated with this procedure, which was superior to endovascular therapies (intravenous tissue plasminogen activator application or intraarterial thrombolysis).
William J. Powers, Chapel Hill, USA Dr. Horiuchi and colleagues have documented their experience with 58 patients treated by urgent EC-IC bypass for acute ischemic stroke based on retrospective medical records review. These patients' diffusionweighted images revealed no abnormal findings or minimum early signs and medical therapy with heparin infusion and oral antiplatelet drugs failed to provide sufficient recanalization and halt progression of ischemic symptoms. Presumed atherosclerotic stenosis or occlusion of the internal carotid artery (ICA) or middle cerebral artery (MCA) was confirmed by angiography. Thirty-four (58.6 %) were operated the day of onset and most were operated within 2 days. Postoperative MR angiography and/or angiogram showed a patent bypass in 37 of 38 in whom it was performed. No patient received intravenous tPA, though it is not stated how many would have met eligibility criteria. New infarction developed in 23 (40 %), and major complications occurred in 4 including one death due to myocardial infarction. Forty-three (74 %) patients had favorable (Glasgow outcome score 4-5) and 15 (26 %) patients had unfavorable (Glasgow outcome score, 1-3) outcome.
How do these data help us in treating patients with acute stroke with stenosis or occlusion of the MCA or ICA? They do not. In the absence of a randomized control group, it is impossible to determine if the EC-IC bypass surgery helped or hurt these patients. The 74 % rate of favorable outcome is likely due to the careful selection of patients to exclude those with a large diffusion lesion, a major determinant of poor outcome after stroke [1] . A patent bypass is not evidence of clinical efficacy; reperfusion will only ameliorate the effects of acute ischemic stroke if performed very rapidly, probably within <4.5 h and even then not in all cases [2] [3] [4] . Recent data from trials of intra-arterial intervention have shown that reperfusion >6 h in those with persistent ICA or MCA occlusion provides no benefit [5] and even delays of one hour render the better recanalization achieved by intra-arterial approaches no better than intravenous tPA [6] . Thus, revascularization by EC-IC bypass as reported here is highly unlikely to prove to be of benefit even if tested in a randomized, controlled trial. The treatment of choice for those with acute ischemic stroke with MCA or ICA occlusion who met NINDS or ECASS III criteria is intravenous tPA and for those who do not, it is anti-platelet therapy [2, 3, 7, 8 Rod Samuelson, Phoenix, USA The authors present and important series of 58 patients with emergent EC-IC bypass for symptomatic atherosclerotic ischemic stroke. The included patients presented with acutely symptomatic stenosis or occlusion of the cervical/intracranial internal carotid artery or M1 / M2 middle cerebral artery. This group of patients was not evaluated in the larger (negative) trials for EC-IC bypass. Patient selection was by a careful process including severe symptoms, favorable neuroimaging, and lack of response to basic medical interventions. Endovascular interventions were used on an unspecified number of patients as well.
In general, the patients had favorable outcomes, and 69 % had improved neurologic function postoperatively. However, 40 % of the patients went on to have strokes in the affected vascular territory. This is an important series of patients for study and consideration, although the algorithm for stroke treatment in these patients is somewhat different than that advocated by the American Heart Association/ American Stroke Association. My main reservation with this paper is that some of the included patients may have benefited from IV tPA or additional endovascular treatments. Intracranial atherosclerosis is not a contraindication for IV tPA that I am familiar with. Nevertheless, when patients are treated with emergent EC-IC bypass, they appear to have a similar potential for favorable outcome as those treated with IV tPA or intra-arterial interventions.
For future study, comparison with patients who receive "standard" therapies is in order. Intracranial balloon angioplasty and stenting is also an attractive alternative.
Albert van der Zwan, Utrecht, The Netherlands The study of Dr Horiuchi and colleagues clearly demonstrates that early bypass surgery in a broad cohort of symptomatic internal carotid artery or the middle cerebral artery stenosis of occlusion can be done safely performed within 2 days after the first ictus. Although previous publications describe hyperperfusion rates between 0.6 and 15 %, the results of this study are splendid with no hyperperfusion complications having occurred. 1, 2, 3 Yet, it is still unclear what the reason is for this. The explanation of this by suggesting that more proximal diseases like in this study could be the reason for this is not very strong as MCA stenosis is not only proximally located per se.
Yet, the absence of hemorrhagic conditions cannot be the final goal of a study to determine a role for EC-IC bypass surgery in ischemic cerebral conditions. As the authors already denoted, this is a retrospective study on bypass surgeries performed on a broad scale of patients groups (stenosis or occlusion of the precommunicating ICA and postcommunicating ICA and MCA), still without DWI image infarcts, using one or two EC-IC bypasses without determining added blood flows.
This diversity of patients and therapy in this study is the reason that this study will not help us in deciding whether bypass surgery will be beneficial for a selected group of patients.
Stenosis or occlusion of any artery and the existence of sufficient collaterals play an important role in the final outcome. In addition, it is unclear whether in this cohort of patients pure hemodynamic or additional embolic factors play a role in the neurological outcome. The existence of a stenosis does not tell us whether any infarction is originated in embolus or hemodynamics. In addition, the assessment of the Glasgow Coma (Outcome) Scale in inclusion and follow-up could miss essential factors in patient assessment 4 . The therapeutical window in this study varied between 0 and 2 days. In addition, this relatively broad time frame could disturb the results. Moreover, the use of one or two bypasses based on ICG does not give any information about flows that are added to the specific patients. ICG is, until now, no flow measurement technique. In the best, it can give information about flow velocities and direction. Therefore, to our experience, added flows in this study may vary between 10 and 90 ml/min which is again a broad spectrum.
Finally, the described 74.1 % of patients having favorable outcome does not tell us what the additional value of the bypass was in these patients. In the COSS study, the functional outcome of the nonsurgical patients was much better than in previous studies (follow up, 2 years), and it is difficult to compare the results of the present study (follow up at discharge) with the COSS study. 4 In conclusion, this study is helpful in the discussion on the risk of hemorrhagic complications of acute bypass surgery, but does not help us in the search for selected patients that could benefit from this type of surgery. For that, we need more specific pathology inclusion, more defined functional investigations (MRI, MRF, and MRS), and more quantitative data on the added flows than has been used in this (or COSS) study.
